You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Aspirin a day keeps bowel cancer at bay
- 2. USP39: a key regulator in malignant tumor progression
- 3. Top biotech deals in June 2025
- 4. Stereotactic total ablative radiotherapy with MR-LINAC for synchronous oligometastatic prostate cancer
- 5. Johnson & Johnson submits application to the European Medicines Agency seeking indication extension of AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of adult patients with metastatic hormone-sensitive prostate cancer and HRR gene alterations
- 6. Impact of pediatric anesthesia management on cancer outcomes in children—a narrative review
- 7. Inflammatory-based prognostic indicators in prostate cancer: evaluating NLR, PLR, and SII in relation to Cambridge and ISUP classifications
- 8. PI-RADSv2.1 combined with PSA density for optimizing prostate biopsy decisions: a retrospective analysis
- 9. Case Report: A patient with metastatic bladder cancer in the stomach
- 10. FN1 from cancer-associated fibroblasts orchestrates pancreatic cancer metastasis via integrin-PI3K/AKT signaling
Last updated at 17:17 GMT
Hot News Makers
Health/Pharma Companies
-
2454.07
-
872.92
-
560.49
-
377.62
-
336.79
-
314.04
-
179.66
-
137.97
-
59.51
-
23.19
Drugs, Treatments, Trials
-
181.55
Last updated at 17:10 GMT
